Shilpa Medicare Forms Death Cross, Signaling Potential Bearish Trend Ahead
Shilpa Medicare has recently encountered a technical event known as a Death Cross, indicating potential bearish momentum. The stock has underperformed over the past year, despite a recent weekly gain. Current valuation metrics suggest concerns, and bearish indicators may prompt closer examination of the company's market position.
Shilpa Medicare, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a significant technical event known as a Death Cross. This occurs when a stock's short-term moving average crosses below its long-term moving average, often signaling a potential shift in market sentiment and indicating bearish momentum.Today, Shilpa Medicare's stock price declined by 2.10%, contrasting with the Sensex's marginal gain of 0.01%. Over the past year, the stock has underperformed, showing a decline of 6.29%, while the Sensex has risen by 8.74%. Despite a positive performance over the past week, with a 5.81% increase, the three-month outlook remains concerning, as the stock has dropped by 13.70%.
The current P/E ratio of Shilpa Medicare stands at 55.54, significantly higher than the industry average of 34.41, which may suggest overvaluation concerns. With bearish indicators from the MACD and KST, alongside a mildly bearish outlook from moving averages, investors may need to exercise caution. The implications of the Death Cross could lead to further scrutiny of Shilpa Medicare's market position and performance in the coming weeks.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
